ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers

Na Jing(Dalian Medical University), Helen He Zhu(Shanghai Cancer Institute), Kaiyuan Liu(Fudan University), Wei‐Qiang Gao(Renji Hospital), Wentian Zhang(Tongji University), Xinyu Chen(Jiangsu University), Zhongzhong Ji(Shanghai Cancer Institute), Yuman He(Shanghai Jiao Tong University), Guanglei Zhuang(Shanghai Jiao Tong University), Kai Zhang(Chinese Academy of Sciences), Qi Wang(Wenzhou Medical University), Wei Xue(Kunming University), Pengfei Ma(First Affiliated Hospital of Zhengzhou University), Liancheng Fan(Shanghai Jiao Tong University), Yingchao Zhang(Chinese Academy of Sciences), Deng Wang(Shanghai Jiao Tong University), Yujiao Sun(Shanghai Cancer Institute), Penghui Xu(Unknown), Wei Bao(Shanghai Cancer Institute), Lingling Xiao(Shanghai University of Traditional Chinese Medicine), Yiming Gong(Shanghai Cancer Institute), Baijun Dong(Shanghai Jiao Tong University), Pengcheng Zhang(Xijing Hospital), Chaping Cheng(Shanghai Cancer Institute), Huifang Zhao(University of Science and Technology of China), Zhixiang Xin(Shanghai Cancer Institute), Yiyi Ji(Shanghai Jiao Tong University)
Journal of Clinical Investigation
December 14, 2023
Cited by 29


Related Papers